UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): October 31, 2006 (October 30,
2006)
|
Chembio
Diagnostics, Inc.
|
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-30379
|
88-0425691
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
3661
Horseblock Road, Medford, NY 11763
(Address
of principal executive offices)
(Zip
Code)
Registrant's
telephone number, including area code (631)
924-1135
|
N/A
|
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[
] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
7.01. Regulation
FD Disclosure.
On
October 30, 2006, the Company issued a press release entitled “Chembio
Diagnostics to Present at 2006 C.E. Unterberg, Towbin Life Sciences Conference
on October 31, 2006.” The press release is attached as Exhibit 99.1 hereto.
On
October 31, 2006, certain officers of the Company will deliver an investor
presentation that will include communication comprised of slides furnished
as
Exhibit 99.2 to this Current Report on Form 8-K and are incorporated herein
by
reference.
On
October 31, 2006, the Company issued a press release
entitled “CORRECTING and REPLACING Chembio Diagnostics to Present at 2006 C.E.
Unterberg, Towbin Life Sciences Conference on October 31, 2006.” The press
release is attached as Exhibit 99.3 hereto.
In
accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K shall not be deemed “filed” for the purpose of
Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed
incorporated by reference in any filing. This Current Report on Form 8-K does
not constitute a determination of whether any information included herein is
material.
Item
9.01 Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description
of Exhibit
|
|
99.1
|
|
|
99.2
|
|
|
99.3
|
Press Release dated October 31, 2006 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date:
October 31, 2006 CHEMBIO
DIAGNOSTICS, INC.
By: /s/
Lawrence A. Siebert
Lawrence
A. Siebert
Chief
Executive Officer